Form 4: Immuneering Corp Director Acquires Stock Options

Robert J. Carpenter, a director of Immuneering Corp, acquired stock options for 33,350 shares of Class A Common Stock on June 12, 2024.

Summary

• Robert J. Carpenter, a director of Immuneering Corp, filed a Form 4 on June 13, 2024, reporting a transaction.
• On June 12, 2024, Carpenter acquired stock options for 33,350 shares of Immuneering Corp's Class A Common Stock at an exercise price of $1.54.
• The options vest in equal monthly installments over one year, starting July 12, 2024, and will be fully vested by June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever is earlier.
• Following the transaction, Carpenter directly owns derivative securities for 33,350 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction (stock option grant) to a director, which can be interpreted as a sign of confidence, but it's not a major event.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's increased stake in the company's success.

Key Dates